Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Quintessence Int ; 53(9): 782-789, 2022 Sep 16.
Artículo en Inglés | MEDLINE | ID: mdl-35726548

RESUMEN

OBJECTIVE: To evaluate the effects of zinc oxide-eugenol, calcium hydroxide, and mineral trioxide aggregate as base materials on the clinical and radiographic success of ferric sulfate pulpotomies in primary molars. METHOD AND MATERIALS: Following hemostasis with 15.5% ferric sulfate, 105 teeth were randomly allocated to three groups: Group 1, zinc oxide-eugenol; Group 2, calcium hydroxide; and Group 3, mineral trioxide aggregate. All teeth were restored with stainless-steel crowns. Clinical and radiographic examinations were conducted at 6, 12, 18, and 24 months. RESULTS: After 24 months, clinical success rates for Groups 1 to 3 were 97.1% (34/35 teeth), 94.2% (33/35 teeth), and 97.1% (34/35 teeth), respectively (P > .05). Radiographic success rates were 65.7% (23/35 teeth), 65.7% (23/35 teeth), and 77.1% (27/35 teeth), respectively (P > .05). Internal resorption was the most observed radiographic finding (15/105 teeth). CONCLUSIONS: The choice of zinc oxide-eugenol, calcium hydroxide, and mineral trioxide aggregate, as base materials, did not affect the clinical and radiographic success of ferric sulfate pulpotomies in primary teeth.


Asunto(s)
Pulpotomía , Óxido de Zinc , Compuestos de Calcio/uso terapéutico , Hidróxido de Calcio/farmacología , Hidróxido de Calcio/uso terapéutico , Combinación de Medicamentos , Eugenol/farmacología , Compuestos Férricos , Humanos , Diente Molar/cirugía , Óxidos/uso terapéutico , Pulpotomía/métodos , Silicatos/uso terapéutico , Acero/farmacología , Diente Primario , Resultado del Tratamiento , Óxido de Zinc/farmacología , Cemento de Óxido de Zinc-Eugenol/farmacología , Cemento de Óxido de Zinc-Eugenol/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA